<p>
    Contraindications to Listing:
</p>
<p>
    1. &nbsp;&nbsp;<strong>Co-Morbidities</strong>: Any medical condition reducing the estimated 5-year post-transplant survival below 60%. Unacceptably high peri-operative risk based on multidisciplinary assessment.
</p>
<p>
    2. &nbsp;&nbsp;<strong>Nutritional Status</strong>:
</p>
<ul>
    <li data-list-item-id="e7506f3186337a1127a566b2e132daaa8">
        &nbsp; &nbsp;<strong>BMI &gt; 45 kg/m²</strong>: Absolute contraindication (except in exceptional circumstances).
    </li>
    <li data-list-item-id="e985f9f81afcd923ca0d5d7eecece1e01">
        &nbsp; &nbsp;<strong>BMI &gt; 40 kg/m²</strong>: Relative contraindication due to increased risk of morbidity/mortality.
    </li>
    <li data-list-item-id="edc8558b64bbe4966a7214ceeaa2ac8d6">
        &nbsp; &nbsp;<strong>BMI &lt; 18.5 kg/m²</strong>: Relative contraindication; aggressive nutritional support should be implemented.
    </li>
</ul>
<p>
    3. &nbsp;&nbsp;<strong>Infections</strong>
</p>
<ul>
    <li data-list-item-id="e15fcab6d4e0a02f007c0233a9d8776b5">
        &nbsp; &nbsp;Active or uncontrolled extrahepatic infection, including sepsis.
    </li>
    <li data-list-item-id="e404dddb62b637a8639bbaaebd4481592">
        &nbsp; &nbsp;Uncontrolled HIV (Detectable viral load <strong>and/or</strong> CD4 count &lt; 100 cells/μL) or <strong>AIDS</strong>.
    </li>
</ul>
<p>
    4. &nbsp;&nbsp;<strong>Malignancy</strong>
</p>
<ul>
    <li data-list-item-id="eb707decb048f2ba01fe109c0827faeaf">
        &nbsp; &nbsp;Presence of active extrahepatic malignancy.
    </li>
    <li data-list-item-id="e8a404b5c145f75fb2f083bd416251faf">
        &nbsp; &nbsp;General requirement: 2–5 years cancer-free after curative treatment, depending on cancer type/stage.
    </li>
    <li data-list-item-id="e1e0dfdb043acd05d36bad9433fba475c">
        &nbsp; &nbsp;Individual assessment may be made for select malignancies.
    </li>
</ul>
<p>
    5. &nbsp;&nbsp;<strong>Vascular Abnormalities</strong>
</p>
<ul>
    <li data-list-item-id="eb0a9fa45769718694702ffa85181b86d">
        &nbsp; &nbsp;Extensive thrombosis or anomalies involving:
        <ul>
            <li data-list-item-id="e607d190e0bb20c5176d52a81c5378e96">
                &nbsp; &nbsp;<strong>Portal vein</strong>
            </li>
            <li class="ck-list-marker-bold" data-list-item-id="e2fdcf3be22cfb1711a3eba8f6a421e8a">
                <strong>&nbsp; &nbsp;Superior mesenteric vein</strong>
            </li>
            <li class="ck-list-marker-bold" data-list-item-id="e5398dbfb29a5a206c708af68603c1f9b">
                <strong>&nbsp; &nbsp;Splenic vein</strong>
            </li>
        </ul>
    </li>
    <li data-list-item-id="ef6077c7f9363debb9ca043bc88d26233">
        &nbsp; &nbsp;Any condition preventing adequate <strong>graft revascularization</strong>.
    </li>
</ul>
<p>
    6. &nbsp;&nbsp;<strong>Psychosocial Considerations</strong>
</p>
<ul>
    <li data-list-item-id="e360a742de60028167bd4f7d89d42104a">
        &nbsp; &nbsp;Unstable psychiatric disorder that may interfere with adherence.
    </li>
    <li data-list-item-id="e5dfa589c74669e97e245bf304b6201cd">
        &nbsp; &nbsp;Illicit drug misuse within the last 6 months.
    </li>
    <li data-list-item-id="eaaece8101d6ba8e4118ddea136ed9bcb">
        &nbsp; &nbsp;Documented or current non-adherence to medical advice.
    </li>
    <li data-list-item-id="e8d4707b65c4168a4ea3611f42e13155e">
        &nbsp; &nbsp;Inadequate social support to ensure post-operative medication compliance and follow-up care.
    </li>
</ul>
<p>
    References:
</p>
<p>
    <i>Trillium Gift of Life - Ontario’s Adult Referral and Listing Criteria for Liver Transplantation&nbsp;</i>
</p>